Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1239588-11-4
1245823-50-0
1286281-32-0
13937-08-1
1446282-18-3
149577-05-9
1292268-13-3 | N-Boc-peg7-alcohol | AA019E90 | MFCD29049415
1343472-07-0 | Azido-PEG8-CH2CO2H | AA019EDJ | MFCD30729542
2183440-70-0 | N-(Azido-PEG3)-N-(PEG2-amine)-PEG3-acid | AA019EH0 | MFCD31615449
854602-86-1 | 4-BROMOALPHA-CHLOROBENZALDOXIME | AA019EK9 | MFCD01013584
117823-72-0 | diethyl 2-(3-methoxybenzyl)succinate | AA019EMZ | MFCD31555350
1209488-61-8 | tert-Butyl 2-(((benzyloxy)carbonyl)amino)-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4h)-carboxylate | AA019EQE | MFCD30185095
170026-02-5 | 2-(2-Methoxypyridin-4-yl)ethanamine dihydrochloride | AA019ETP | MFCD28991725
909563-22-0 | Methyl 4-amino-2-isopropoxybenzoate | AA019EWT | MFCD24624427
1047630-55-6 | 5-Chloro-4-(1-methyl-1H-pyrazol-5-yl)thiophene-2-carboxylic acid | AA019EZY | MFCD30489217
1379294-26-4 | 6-Bromopyridazin-4-amine | AA019FV0 | MFCD20257795